Methyl salicylate is the defining salicylate ester of wintergreen and sweet birch style materials, often dominating those oils almost completely. Public evidence for this constituent is unusually strong on identity, topical-counterirritant use, dermal absorption, and poisoning risk. Archive summaries should treat it as a well-characterized aroma chemical with real topical pain-relief history but also with significant salicylate safety constraints, especially for children, ingestion risk, and high-concentration topical exposure.
Chemical identity and composition
NIST lists methyl salicylate as C8H8O3, CAS 119-36-8, and notes common names including oil of wintergreen and gaultheria oil. In the archive it functions as the dominant chemotype marker for wintergreen materials, where oil records describe it as roughly 94% to near-100% of the composition. Its pharmacology is tied to hydrolysis to salicylic acid after exposure.
Aroma and practical use
- Use the recorded wintergreen, minty-sweet, medicinal, balsamic descriptors to explore a blend's scent character; perceived strength also depends on the other ingredients.
- Read the route, preparation and experimental context before using a study finding to choose an oil.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
topical pain relief context
A controlled human study reported that a patch containing methyl salicylate and l-menthol provided significant relief of mild to moderate muscle-strain pain during a single 8-hour application, supporting a topical counterirritant use context.
Measured: pain relief over 8 hours
Apply this finding only to the studied preparation, participants, route and outcome. It does not establish the same result for a custom oil blend.
dermal absorption and systemic exposure
Human absorption work summarized in the CIR review found measurable plasma salicylate after topical methyl salicylate cream use, while concluding that plasma concentrations from the cream were not equivalent to those after wintergreen oil ingestion.
Measured: plasma salicylate concentrations
Apply this finding only to the studied preparation, participants, route and outcome. It does not establish the same result for a custom oil blend.
salicylate toxicity and absorption risk
Poisoning reviews describe methyl salicylate as a recurrent cause of serious salicylate exposure, with persistent reports of life-threatening and fatal toxicity, especially in pediatric accidental ingestion scenarios.
Measured: severity of accidental or excessive exposure
The source assessment applies to its specified exposure and preparation; this entry is not an unrestricted-use clearance.
Use concerns and concentration limits
Sensitization concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Penetration enhancementNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
A recorded constituent reference, not a recommended oil dilution. Product category, source applicability and all contributing oils must be checked before use.
unverified reference · No source provenance attachedThe SCCS concluded that methyl salicylate can be considered safe in cosmetics only up to specified product-type maximum concentrations and evaluated it in the context of an expected EU reproductive-toxicity category 2 classification.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
CIR and poisoning reviews document meaningful dermal absorption and serious toxicity risk from ingestion, over-application, or heat/occlusion-enhanced topical exposure.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
Archive summaries should keep the distinction between regulated topical-drug use and essential-oil use clear, because wintergreen-rich materials can deliver salicylate exposure far beyond ordinary fragrance levels.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
Constituents it may interact with
No constituent-pair interaction is recorded for this identity. The report does not assume either amplification or incompatibility.
How the effects were investigated
hydrolysis to salicylate with systemic absorption
Safety reviews note that methyl salicylate is rapidly hydrolyzed to salicylic acid and that measurable salicylate concentrations can occur after topical use, explaining both its counterirritant use context and its toxicity profile.
The source assessment applies to its specified exposure and preparation; this entry is not an unrestricted-use clearance.
platelet aggregation reduction reported in humans
A human volunteer study reported that topical methyl salicylate decreased platelet aggregation, reinforcing that systemic salicylate-relevant effects can follow topical exposure.
Apply this finding only to the studied preparation, participants, route and outcome. It does not establish the same result for a custom oil blend.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (5)
- Most accessible efficacy evidence concerns topical drug products or combinations rather than isolated aroma-use exposures.
- Public safety literature is much stronger than wellness or mechanism literature for this constituent.
- Archive users should not infer broad therapeutic benefit from wintergreen-like aroma alone, because dose and exposure route are central to both effect and risk.
- The numeric dermal reference lacks source provenance; a verified flag alone is insufficient.
- Some findings do not record an explicit exposure route; consult the linked study before applying them to a use.